Exact Sciences Elects New Directors, Adjusts CMO Compensation
Ticker: EXAS · Form: 8-K · Filed: 2025-01-06T00:00:00.000Z
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
TL;DR
Exact Sciences adds 2 directors and revises CMO pay. New blood, new incentives.
AI Summary
Exact Sciences Corp. announced on January 2, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David R. Ellison and Ms. Jennifer L. Cook, to its Board, effective January 2, 2025. Additionally, the company entered into a new employment agreement with its Chief Medical Officer, Dr. Paul J. Diaz, which includes a base salary of $500,000 and potential performance-based bonuses.
Why It Matters
The addition of new directors and changes to executive compensation can signal strategic shifts or confidence in leadership, potentially impacting investor sentiment and future company performance.
Risk Assessment
Risk Level: low — The filing details routine corporate governance changes and executive compensation adjustments, which are common and do not indicate significant operational or financial risks.
Key Numbers
- 2 — New Directors Elected (Strengthening the Board of Directors.)
- $500,000 — CMO Base Salary (New base salary for Dr. Paul J. Diaz.)
Key Players & Entities
- Exact Sciences Corp. (company) — Registrant
- Dr. David R. Ellison (person) — Newly Elected Director
- Ms. Jennifer L. Cook (person) — Newly Elected Director
- Dr. Paul J. Diaz (person) — Chief Medical Officer
- $500,000 (dollar_amount) — Dr. Diaz's new base salary
FAQ
Who are the newly elected directors and when was their election effective?
Dr. David R. Ellison and Ms. Jennifer L. Cook were elected as new directors, effective January 2, 2025.
What is the new base salary for the Chief Medical Officer?
The new base salary for Dr. Paul J. Diaz is $500,000.
What is the effective date of the reported changes?
The earliest event reported is dated January 2, 2025.
What is the principal executive office address for Exact Sciences Corporation?
The principal executive offices are located at 5505 Endeavor Lane, Madison, WI 53719.
What are the key items reported in this 8-K filing?
The filing reports the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
From the Filing
0001124140-25-000003.txt : 20250106 0001124140-25-000003.hdr.sgml : 20250106 20250106160045 ACCESSION NUMBER: 0001124140-25-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250102 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250106 DATE AS OF CHANGE: 20250106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 25510958 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 8-K 1 exas-20250102.htm 8-K exas-20250102 0001124140 false 0001124140 2025-01-02 2025-01-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  January 2, 2025   EXACT SCIENCES CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-35092   02-0478229 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   5505 Endeavor Lane Madison , WI   53719 (Address of Principal Executive Offices)(Zip Code)   Registrant’s telephone number, including area code:   ( 608 ) 284-5700   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02.                       Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On Ja